首页 | 本学科首页   官方微博 | 高级检索  
检索        

帕利哌酮缓释片与齐拉西酮片治疗精神分裂症的对照研究
引用本文:董苒,高昕,陆恩光,张京华,葛红敏,崔鹏,杨会增,韩冬昱.帕利哌酮缓释片与齐拉西酮片治疗精神分裂症的对照研究[J].职业与健康,2011,27(24):2943-2944.
作者姓名:董苒  高昕  陆恩光  张京华  葛红敏  崔鹏  杨会增  韩冬昱
作者单位:天津市安定医院一科,300222
摘    要:目的 探讨帕利哌酮缓释片与齐拉西酮片治疗精神分裂症的疗效和安全性.方法 将60例精神分裂症患者随机分为帕利哌酮研究组30例和齐拉西酮对照组30例,各观察8周.分别与治疗前和治疗1、2、4和8周采用阳性与阴性症状量表(PANSS)评价其疗效.通过体检、实验室检查、心电图检查及其他不良事件的收集评价其安全性.结果 研究组显效率和有效率分别为73.3%和86.7%,对照组分别为70.0%和80.0%,2组之间差异无统计学意义(P>0.05).2组不良反应率比较,差异无统计学意义(P>0.05),不良反应均较轻.结论 帕利哌酮缓释片治疗精神分裂症疗效与齐拉西酮相当.

关 键 词:帕利哌酮  齐拉西酮  精神分裂症

A Comparative Study of Paliperidone Sustained-release Tablets and Ziprasidone Tablets for Schizophrenia
DONG Ran , GAO Xin , LU En-guang , ZHANG Jing-hua , GE Hong-mie , CHUI Peng , YANG Hui-zeng , HAN Dong-yu.A Comparative Study of Paliperidone Sustained-release Tablets and Ziprasidone Tablets for Schizophrenia[J].Occupation and Health,2011,27(24):2943-2944.
Authors:DONG Ran  GAO Xin  LU En-guang  ZHANG Jing-hua  GE Hong-mie  CHUI Peng  YANG Hui-zeng  HAN Dong-yu
Institution:DONG Ran,GAO Xin,LU En-guang,ZHANG Jing-hua,GE Hong-min,YANG Hui-zeng,HAN Dong-yu(The First Department,Tianjin Anding Hospital,Tianjin,300222,China)
Abstract:Objective]To study the efficacy and safety of paliperidone sustained-release tablets and ziprasidone tablets for schizophrenia. Methods]60 patients with schizophrenia were randomly divided into the study group(paliperidone,30 cases) and the control group(ziprasidone,30 cases),and two groups were observed for 8 weeks.The efficacy was assessed by positive and negative symptom scale(PANSS) before and at the end of 1,2,4 and 8 weeks of treatment respectively.The safety was evaluated by physical examination,la...
Keywords:Paliperidone  Ziprasidone  Schizophrenia  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号